Zobrazeno 1 - 8
of 8
pro vyhledávání: '"I. F. Chernyad'eva"'
Publikováno v:
Bulletin of Experimental Biology and Medicine. 135:436-439
The hypolipidemic effect of Kwai, a preparation based on garlic powder (Allium sativum), depended on the initial content of cholesterol and/or triglycerides. This effect was most pronounced in patients with coronary heart disease with initial cholest
Publikováno v:
Bulletin of Experimental Biology and Medicine. 133:354-356
Plasma contents of apolipoprotein (a), apolipoprotein B 100, cholesterol, triglycerides, and vitamin E were measured in 2 patients with lipoprotein (a) concentration >100 mg/dl during the interaction with the anti-lipoprotein (a) immunosorbent. Intra
Autor:
I. F. Chernyad'eva, K. A. Shestakov, V. V. Kukharchuk, V. I. Kulikov, G. I. Muzya, N. S. Bol'shakova
Publikováno v:
ChemInform. 26
Publikováno v:
Bulletin of Experimental Biology and Medicine. 125:187-189
Plasma level of lipid-standardized vitamin E is decreased, while the concentration of inflammatory transmitters C3a(desArg) and C5a(desArg) is elevated in heterozygous familial hypercholesterolemia caused by apoB,E-receptor deficiency. Leukocytes iso
Publikováno v:
Bulletin of Experimental Biology and Medicine. 123:248-250
The effects of astaxanthine and β-carotene on the oxidation of isolated human plasma apoB-lipoproteins induced by copper ions or hemin/hydrogen peroxide are studied. Astaxanthine inhibits the formation of both primary (diene conjugates) and secondar
Publikováno v:
Bulletin of experimental biology and medicine. 135(5)
The hypolipidemic effect of Kwai, a preparation based on garlic powder (Allium sativum), depended on the initial content of cholesterol and/or triglycerides. This effect was most pronounced in patients with coronary heart disease with initial cholest
Publikováno v:
Bulletin of experimental biology and medicine. 133(4)
Plasma contents of apolipoprotein (a), apolipoprotein B 100, cholesterol, triglycerides, and vitamin E were measured in 2 patients with lipoprotein (a) concentration100 mg/dl during the interaction with the anti-lipoprotein (a) immunosorbent. Intrain
Autor:
K. A. Shestakov, G. I. Muzya, I. F. Chernyad'eva, V. V. Kukharchuk, V. I. Kulikov, N. S. Bol'shakova
Publikováno v:
Pharmaceutical Chemistry Journal. 29:333-334